Search

everythinglearnresearchcommunity

for

Search:↓

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

Dupilumab treatment reduces Th2-related markers and helps hair growth in alopecia areata, showing Th2's role in the condition.

Sintilimab treatment caused hair loss but led to complete tumor remission.

The woman was diagnosed with systemic lupus erythematosus (SLE) after initial misdiagnosis and improved with proper treatment.

The role of γδT-cells in causing alopecia areata remains unclear.

A medication for skin rash also unexpectedly treated hair loss in a patient.

Bexxar is highly effective as a first treatment for non-Hodgkin's lymphoma, with most patients alive and many in remission after eight years.

Dupilumab helped a woman with severe hair loss regrow her hair quickly and maintain it for six months after stopping treatment.

A specific genetic trait in tumor cells is linked to longer survival without disease in certain lymphoma patients.

A woman in Sri Lanka was diagnosed with lupus after presenting with protein loss from the gut and other symptoms.

Repeated biopsies are crucial for managing lupus panniculitis when initial treatments fail.

Using CD123 to detect certain immune cells helps diagnose a type of hair loss condition.

Machine learning can help identify biomarkers for personalized Pemphigus vulgaris treatment.

Treatment with prednisolone and dapsone stopped new blisters and partially healed previous ones.

Mice with alopecia areata had wider lymphatic vessels in their skin.

Rituximab leads to longer remission and fewer side effects than cyclophosphamide.

A woman with severe angioedema improved significantly after treatment with rituximab.

ApoBDs, once seen as waste, are now viewed as potential tools for disease treatment and tissue repair.

Dupilumab can help regrow hair and improve skin conditions in patients with severe atopic dermatitis and alopecia areata.

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

Telitacicept effectively improved hair regrowth in a woman with lupus and alopecia.

Deucravacitinib improves symptoms and reduces inflammation in Lichen Planopilaris.

UTMD with diclofenac and Doxil® improves cancer treatment by boosting immune response and reducing tumor-supporting cells.

Discoid Lupus Erythematosus causes scalp plaques that can lead to hair loss, and antimalarial drugs are effective treatments.

Bendamustine, often combined with other drugs, is effective and less toxic for certain blood cancers, but less effective for young, fit patients with CLL.

A patient with a rare form of lupus improved after treatment for skin ulcers and hair loss on the face and scalp.

Eculizumab helps reduce blood transfusions and stabilize hemoglobin but increases infection risk and is expensive.

Topical squaric acid dibutylester worsened discoid lupus erythematosus in a patient.

DDS treatment for LABD can cause severe side effects like anemia and hair loss, requiring careful monitoring.